P-glycoprotein
P-glycoprotein (P-gp) also known as multidrug resistance protein 1 (MDR1) is an important protein of the cell membrane that pumps many foreign substances out of cells. More formally, it is an ATP-dependent efflux pump with broad substrate specificity. P-gp is extensively distributed and expressed in the intestinal epithelium where it pumps xenobiotics (such as toxins or drugs) back into the intestinal lumen, in liver cells where it pumps them into bile ducts, in the cells of the proximal tubular of the kidney where it pumps them into urine-conducting ducts, and in the capillary endothelial cells comprising the blood–brain barrier and blood-testis barrier, where it pumps them back into the capillaries. Some cancer cells also express large amounts of P-gp, which renders these cancers multi-drug resistant. P-gp is an ATP-dependent drug efflux pump for xenobiotic compounds with broad substrate specificity. It is responsible for decreased drug accumulation in multidrug-resistant cells and often mediates the development of resistance to anticancer drugs. This protein also functions as a transporter in the blood–brain barrier.
Targets for P-glycoprotein
Products for P-glycoprotein
- Cat.No. Product Name Information
-
GC60407
(R)-Verapamil D7 hydrochloride
(R)-(+)-Verapamil D7 hydrochloride
(R)-Verapamil D7 hydrochloride ((R)-(+)-Verapamil D7 hydrochloride) is a deuterium labeled (R)-Verapamil hydrochloride. (R)-Verapamil hydrochloride ((R)-(+)-Verapamil hydrochloride) is a P-Glycoprotein inhibitor. (R)-Verapamil hydrochloride blocks MRP1 mediated transport, resulting in chemosensitization of MRP1-overexpressing cells to anticancer drugs. -
GC60408
(R)-Verapamil hydrochloride
(R)-Verapamil hydrochloride ((R)-(+)-Verapamil hydrochloride) is a P-Glycoprotein inhibitor. (R)-Verapamil hydrochloride blocks MRP1 mediated transport, resulting in chemosensitization of MRP1-overexpressing cells to anticancer drugs.
-
GC30371
Alisol F
Alisol F is a triterpene isolated from Alisma orientalis, has immunosuppressive and anti-virus functions.
-
GC12945
Atazanavir
BMS 232632, CGP 73547
An inhibitor of HIV-1 protease -
GC10240
Atazanavir sulfate (BMS-232632-05)
An inhibitor of HIV-1 protease
-
GC64274
AZD-5672
AZD-5672 is an orally active, potent, and selective CCR5 antagonist (IC50=0.32 nM).
-
GC33338
Biricodar (VX-710)
VX-710
Biricodar (VX-710) (VX-710) is a modulator of P-glycoprotein and MRP-1; shows effective chemosensitizing activity in multidrug resistant cells. -
GC71999
Boeravinone B
Boeravinone B, a dual inhibitor of NorA bacterial efflux pump of Staphylococcus aureus and human P-Glycoprotein, reduces the biofilm formation and intracellular invasion of bacteria.
-
GC35692
Chrysosplenetin
Chrysosplenol B, Chrysosptertin B, EMD 20940, Polycladin
A flavonoid with diverse biological activities -
GC35727
Coniferyl ferulate
A monolignal conjugate with diverse biological activities
-
GC39701
Convallatoxin
Convallatoxin is a cardiac glycoside isolated from Adonis amurensis Regel et Radde.
-
GC35892
Dofequidar
A quinoline derivative and inhibitor of multidrug resistance
-
GC13375
Dofequidar fumarate
MS-209
MDR reversal agent -
GC17215
Elacridar
GF120918, GG918, GW0918
An inhibitor of MRP-1 and BCRP -
GC17163
Elacridar hydrochloride
An inhibitor of MRP-1 and BCRP
-
GC31340
Encequidar (HM30181)
Encequidar
Encequidar (HM30181) (HM30181; HM30181A) is a potent and selective inhibitor of P-glycoprotein. -
GC33185
Encequidar mesylate (HM30181 (mesylate))
HM30181 mesylate; HM30181A mesylate
HM30181 mesylate salt, a tetrazole derivative, is known as a P-glycoprotein inhibitor that has inhibitory activities on multidrug resistance in cancer cells. -
GC36034
FD 12-9
Ac12Az9
FD 12-9 is a flavonoid dimer, acts as a dual inhibitor of P-gp and BCRP, with EC50s of 285 nM and 0.9 nM, respectively. Anti-glioblastoma activity. -
GC65385
Ganoderenic acid B
Ganoderenic acid B is a lanostane-type triterpene isolated from Ganoderma lucidum. Ganoderenic acid B exhibits potent reversal effect on ABCB1-mediated multidrug resistance of HepG2/ADM cells to Doxorubicin.
-
GC73573
hCA/Wnt/β-catenin-IN-1
hCA/Wnt/β-catenin-IN-1 (Compd 15) is an inhibitor of hCA (Ki: 33.6, 24.1, 6.8 nM for hCA II, hCA IX, hCA XII). hCA/Wnt/β-catenin-IN-1 reduces P-gp activity.
-
GC10391
Hypophyllanthin
NSC 619044
P-glycoprotein (P-gp) inhibitor -
GC36345
Isosinensetin
6-Demethoxynobiletin
Isosinensetin, a polymethoxylated flavone extracted from pericarpium citri reticulatae viride, exhibits inhibition on P-glycoprotein (P-gp) in MDR1-MDCKII cells. -
GC16609
LY335979 (Zosuquidar 3HCL)
RS 33295-198; Zosuquidar trihydrochloride; LY335979; LY-335979
Zosuquidar (LY335979) trihydrochloride is a P-glycoprotein (P-gp) inhibitor (Ki=59 nM). LY335979 (Zosuquidar 3HCL) shows anti-tumor activities, and can be used in acute myelogenous leukemia (AML) research. -
GC33375
MCI826
MCI826 is a P-glycoprotein (P-gp) antagonist.
-
GC32518
Norverapamil hydrochloride ((±)-Norverapamil hydrochloride)
D 591
Norverapamil hydrochloride ((±)-Norverapamil hydrochloride) ((±)-Norverapamil hydrochloride ((±)-Norverapamil hydrochloride)), an N-demethylated metabolite of Verapamil, is a L-type calcium channel blocker and a P-glycoprotein (P-gp) function inhibitor. -
GC18470
NSC 23925
An inhibitor of P-gp
-
GC65183
P-gp inhibitor 1
P-gp inhibitor 1 is a novel inhibitor reversing P-glycoprotein-mediated multidrug resistance.
-
GC36891
P-gp modulator 1
P-gp modulator 1 is a high affinity, orally available modulator of P-glycoprotein (Pgp), can reverse the Pgp-mediated multidrug resistance ((MDR).
-
GC36855
Paris saponin VII
Paris saponin VII (Chonglou Saponin VII) is a steroidal saponin isolated from the roots and rhizomes of Trillium tschonoskii Maxim. Paris saponin VII-induced apoptosis in K562/ADR cells is associated with Akt/MAPK and the inhibition of P-gp. Paris saponin VII attenuates mitochondrial membrane potential, increases the expression of apoptosis-related proteins, such as Bax and cytochrome c, and decreases the protein expression levels of Bcl-2, caspase-9, caspase-3, PARP-1, and p-Akt. Paris saponin VII induces a robust autophagy in K562/ADR cells and provides a biochemical basis in the treatment of leukemia.
-
GN10020
Piperine
Bioperine, NSC 21727, NPiperoylpiperidin
-
GC33151
Polyoxyethylene stearate (POES)
Polyoxyethylene stearate (POES) (POES) is a non-ionic emulsifying agent.
-
GN10805
Protopanaxdiol
20(S)-APPD, 20-Epiprotopanaxadiol
-
GC12523
Reversan
CBLC4H10
inhibitor of multidrug resistance-associated protein 1 (MRP1) and P-glycoprotein (P-gp) -
GC12986
Risperidone
Apexidone, Psychodal, R 64766
SR-2A inhibitor
-
GC63175
Roemerine
(-)-Roemerine, (R)-Roemerine
Roemerine, an aporphine alkaloid, isolated from the leaves of Annona senegalensis, functions by interacting with P-glycoprotein. Roemerine reverses the multidrug-resistance phenotype with cultured cells. -
GC18460
Roquefortine C
NSC 292134
Roquefortine C is a mycotoxin that was first isolated from a strain of P. -
GC32906
Sinapine
Sinapine is an alkaloid isolated from seeds of the cruciferous species.
-
GC30033
Sinapine thiocyanate
Sinapine thiocyanate is an alkaloid isolated from seeds of the cruciferous species. Sinapine thiocyanate exhibits anti-inflammatory, anti-oxidant, anti-tumor, anti-angiogenic and radio-protective effects. Sinapine thiocyanate is also an acetylcholinesterase (AChE) inhibitor and can be used for the research of Alzheimer’s disease, ataxia, myasthenia gravis, and Parkinson’s disease.
-
GC15570
Tariquidar
XR9576
A P-glycoprotein inhibitor -
GC50254
Tariquidar dihydrochloride
XR9576 dihydrochloride
Potent P-glycoprotein (P-gp) inhibitor -
GC10928
Tariquidar methanesulfonate, hydrate
A P-glycoprotein inhibitor
-
GC37832
TTT-28
TTT-28 is a synthesized thiazole-valine peptidomimetic, a novel selective inhibitor of ABCB1 (P-gp/MDR1) with high efficacy and low toxicity, which reverses the ATP-binding cassette sub-family B member 1 (ABCB1)-mediated Multidrug resistance (MDR) by selectively blocking the efflux function of ABCB1.
-
GC16677
Valspodar
Valspodar
Valspodar is a potent inhibitor of P-glycoprotein (P-gp) widely used in preclinical and clinical studies [1]. -
GC61811
Verapamil
Verapamil is an L-type calcium channel blocker and adrenergic receptor antagonist commonly used in studies of hypertension, arrhythmias and angina pectoris.
-
GC45150
Voacamine
NSC 82591
Voacamine is an alkaloid originally isolated from Voacanga that has diverse biological activities. -
GC67920
WS-898
-
GC65184
YS-370
YS-370 (compound 44) is a potent, high selective, and orally active inhibitor of P-glycoprotein (P-gp). YS-370 stimulates the P-gp ATPase activity and has moderate inhibition against CYP3A4. YS-370 effectively reverses multidrug resistance (MDR) to paclitaxel and colchicine in SW620/AD300 and HEK293T-ABCB1 cells. YS-370 in combination with paclitaxel achieves much stronger antitumor activity.
-
GC32593
Zamicastat (BIA 5-1058)
BIA 5-1058
Zamicastat (BIA 5-1058) (BIA 5-1058) is a dopamine β-hydroxylase (DBH) inhibitor and can cross the blood-brain barrier (BBB) to cause central as well as peripheral effects. -
GC16672
Zosuquidar
A modulator of P-gp